Pharmaceutical services provider TrialCard was recently named to the Grant Thornton North Carolina 100 list for the second consecutive year. The annual list recognizes the largest privately-held companies in the state of North Carolina.

TrialCard has experienced significant year-over-year revenue growth during its tenure on the list, driven by the company’s expansion from a niche co-pay savings program company into a full-service integrated solutions provider. In September 2016 TrialCard established TC Market Access as its dedicated patient support (HUB) division, and during the past year has secured multiple HUB services programs supporting products in oncology, neurology, and several other therapeutic classes. TrialCard has also experienced significant growth in its healthcare professional virtual engagement business, conducting tele-promotion and white space coverage campaigns as well as patient lead generation efforts for rare disease orphan drugs.

“Being named to the Grant Thornton North Carolina 100 list for the second year in a row is a tremendous honor,” said TrialCard President and CEO Mark Bouck. “It reflects both our commitment to continue on our path of growth and innovation in support of pharmaceutical manufacturers and the patients they help as well as the dedication of our employees in meeting new challenges.”

Companies named to the 2016 North Carolina list are featured in the October edition of Business North Carolina magazine.

About the Grant Thornton North Carolina 100®
Since 1984, the Grant Thornton North Carolina 100® has ranked the state’s largest private companies by revenue in the most recent fiscal year, based on data provided by the participants. The NC100 is a voluntary list restricted to companies based in North Carolina that do not have publicly traded stock. Companies owned by private equity are permitted. Nonprofits, financial-services companies, health care providers such as hospitals and subsidiaries of corporations are excluded. For more details, visit